Meeting
2016 ASCO Annual Meeting
Correlation of PD-L1 expression with immune cell infiltrates, genome-wide copy number aberrations and survival in mesothelioma.
Authors
Bibhusal Thapa
Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Melbourne, Australia
Bibhusal Thapa , Marzena Walkiewicz , Carmel Murone , Malaka Ameratunga , Khashayar Asadi , Siddhartha Deb , Xihui Lin , Adriana Salcedo , Stephen Barnett , Simon Knight , Paul Mitchell , Paul C Boutros , Neil Watkins , Thomas John
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Mesothelioma
Citation
J Clin Oncol 34, 2016 (suppl; abstr 8518)
DOI
10.1200/JCO.2016.34.15_suppl.8518
Abstract #
8518
Poster Bd #
146
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Assessment of PD-L1 expression and tumor associated immune cells in pediatric cancer tissues.
First Author: Robbie G. Majzner
Poster
2016 ASCO Annual Meeting
Clinicopathological features of program death ligand-1 (PD-L1) expression with tumor-infiltrating lymphocytes (TILs), mismatch repair (MMR) and Epstein-Barr virus (EBV) status in a large cohort of gastric cancer.
First Author: Akihito Kawazoe
Poster
2016 ASCO Annual Meeting
Analysis of immune infiltrates in a genomically characterized clinical cohort of head and neck squamous cell carcinoma (HNSCC) patients (pts).
First Author: Nicole Grace Chau
Poster
2022 ASCO Annual Meeting
Analysis of the contribution of macrophages to the overall tumor PD-L1 microenvironment using a screening multi-tumor tissue microarray and rapid multiplex fluorescence digital phenotyping approach.
First Author: Marie Cumberbatch